Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Newland-Jones

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 26, 2021
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative ReviewKevin Fernando, Stephen C Bain, Patrick Holmes, et al.
Health Technology Assessment (Winchester, England)|August 18, 2025
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility studyRichard Ig Holt, Katharine Barnard-Kelly, Mayank Patel, et al.
British Journal of Anaesthesia|January 30, 2024
Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitusKetan Dhatariya, Nicholas Levy, Kim Russon, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 25, 2018
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical PracticeJohn Wilding, Kevin Fernando, Nicola Milne, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2026
Considerations for the clinical use of teplizumab in stage 2 Type 1 diabetes: A Consensus Statement from the British Society of Paediatric Endocrinology and Diabetes (BSPED) and the Association of British Clinical Diabetologists (ABCD)Renuka P Dias, M Loredana Marcovecchio, Ruben H Willemsen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 30, 2020
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 DiabetesDavid C Wheeler, June James, Dipesh Patel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2020
Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related ComplicationsMarc Evans, Angharad R Morgan, Dipesh Patel, et al.
Anaesthesia|January 9, 2025
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy AssociationKariem El-Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 5, 2024
SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewSamuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Pilot and Feasibility Studies|August 18, 2021
Developing an intervention to optimise the outcome of cardiac surgery in people with diabetes: the OCTOPuS pilot studyRichard I G Holt, Katharine Barnard-Kelly, Giorgos Dritsakis, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 26, 2021
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative ReviewKevin Fernando, Stephen C Bain, Patrick Holmes, et al.
Health Technology Assessment (Winchester, England)|August 18, 2025
Optimising cardiac surgery outcomes in people with diabetes: the OCTOPuS pilot feasibility studyRichard Ig Holt, Katharine Barnard-Kelly, Mayank Patel, et al.
British Journal of Anaesthesia|January 30, 2024
Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitusKetan Dhatariya, Nicholas Levy, Kim Russon, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 25, 2018
SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical PracticeJohn Wilding, Kevin Fernando, Nicola Milne, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2026
Considerations for the clinical use of teplizumab in stage 2 Type 1 diabetes: A Consensus Statement from the British Society of Paediatric Endocrinology and Diabetes (BSPED) and the Association of British Clinical Diabetologists (ABCD)Renuka P Dias, M Loredana Marcovecchio, Ruben H Willemsen, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 30, 2020
SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 DiabetesDavid C Wheeler, June James, Dipesh Patel, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2020
Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related ComplicationsMarc Evans, Angharad R Morgan, Dipesh Patel, et al.
Anaesthesia|January 9, 2025
Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement: A consensus statement from the Association of Anaesthetists, Association of British Clinical Diabetologists, British Obesity and Metabolic Surgery Society, Centre for Perioperative Care, Joint British Diabetes Societies for Inpatient Care, Royal College of Anaesthetists, Society for Obesity and Bariatric Anaesthesia and UK Clinical Pharmacy AssociationKariem El-Boghdadly, Jugdeep Dhesi, Philippa Fabb, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 5, 2024
SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative ReviewSamuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Pilot and Feasibility Studies|August 18, 2021
Developing an intervention to optimise the outcome of cardiac surgery in people with diabetes: the OCTOPuS pilot studyRichard I G Holt, Katharine Barnard-Kelly, Giorgos Dritsakis, et al.
Pageof 2